gynex inc said gynex labs and searle unit monsanto have terminated distribution agreement under which searle had exclusive rights market gynex line generic oral contraceptives this means gynex labs pct owned gynex and pct watson laboratories will not remuneration under distribution agreement beyond 650 000 dlrs received from searle february and march 1986 this has been applied costs inventories searle and gynex labs will both bear costs involved with product recall gynex labs cost estimated 900 000 dlrs shared equally gynex inc and watson said companies ended agreement when was determined searle product line sales and marketing commitment would not allow commit necessary resources for relaunch gynex line oral contraceptives gynex said after launching first two gynex products early february searle voluntarily recalled them march preventive measure because limited number packages may have contained out order missing tablets gynex has made changes should prevent recurrence problem and ready reinitiate production said talks underway with potential distributors reuter 